(Q41705039)
Statements
1 reference
Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group (English)
1 reference
Tyrrell CJ
1 reference
Denis L
1 reference
Newling D
1 reference
Soloway M
1 reference
Channer K
1 reference
Cockshott ID
1 reference
1 January 1998
1 reference
1 reference
33
1 reference
1
1 reference
39-53
1 reference
Identifiers
1 reference
1 reference